Latest News and Press Releases

San Francisco, CA, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. Selected from...

McLean, VA, July 12, 2023 (GLOBE NEWSWIRE) -- Affect Therapeutics (“Affect”), a company reimagining addiction treatment for the digital age, today announces a $16 million Series A led by...

San Francisco, CA, June 12, 2023 (GLOBE NEWSWIRE) -- Range Biotechnologies (“Range Bio”), a proteomics-focused biotech company that has developed an innovative translational platform to enable...

San Francisco , Dec. 14, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. The 2022 fellows...

San Francisco, Oct. 10, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced Henry Klingenstein has joined the investment...

San Francisco, CA, Dec. 15, 2021 (GLOBE NEWSWIRE) -- ARTIS Ventures, a San Francisco-based venture firm focused on pioneering investments at the intersection of life sciences and computer sciences,...

San Francisco, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- ARTIS Ventures (“AV”), a venture firm focused on pioneering investments in biotech, health, and life sciences, today announced the candidates...

Seattle, WA, March 31, 2021 (GLOBE NEWSWIRE) -- Outpace Bio, a biotechnology company building a platform to create next-generation smart cell therapies, today announced the closing of a $30 million...

San Francisco, CA, July 07, 2020 (GLOBE NEWSWIRE) -- Second Front Systems, a software company working to disrupt the traditional aerospace and defense industry by acting as a beachhead for...

SAN FRANCISCO, April 20, 2020 (GLOBE NEWSWIRE) -- ARTIS Ventures, a venture firm focused on pioneering investments at the intersection of life sciences and computer sciences, today announced that...